52665-48-2 Usage
General Description
Furan-2-sulfonyl chloride, also known as 2-furoyl chloride, is a chemical compound with the molecular formula C5H3ClO2S. It is a colorless to pale yellow liquid that is used as a versatile building block in organic synthesis. Furan-2-sulfonyl chloride is commonly used as a reagent in the production of pharmaceuticals, agrochemicals, and dyes. It is also employed in the synthesis of various functionalized furans, which are important intermediates in the production of fine chemicals and materials. Additionally, furan-2-sulfonyl chloride is utilized in the modification of biologically active compounds to improve their pharmacological properties. However, it is important to handle this compound with caution as it is corrosive and may cause irritation to the skin, eyes, and respiratory system.
Check Digit Verification of cas no
The CAS Registry Mumber 52665-48-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,6,6 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 52665-48:
(7*5)+(6*2)+(5*6)+(4*6)+(3*5)+(2*4)+(1*8)=132
132 % 10 = 2
So 52665-48-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H3ClO3S/c5-9(6,7)4-2-1-3-8-4/h1-3H
52665-48-2Relevant articles and documents
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout
Wang, Weiwei,Pang, Jing,Ha, Eun Hee,Zhou, Mengze,Li, Zhubin,Tian, Sheng,Li, Huanqiu,Hu, Qinghua
supporting information, (2020/01/13)
Gout is a crystalline-related arthropathy caused by the deposition of monosodium urate (MSU). Acute gouty arthritis is the most common first symptom of gout. Studies have shown that NOD-like receptor protein 3 (NLRP3) inflammasome as pattern recognition r
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF
-
Paragraph 0696, (2015/02/25)
Provided are sulfonamide derivatives of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent α4 integrin-inhibitory action.
Heterocyclic sulfonamide inhibitors of beta amyloid production
-
, (2008/06/13)
Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs there